PACBVSSFWL• 28 Days (Normalized)
PACB vs SFWL (Pacific Biosciences of California Inc. vs Shengfeng Development Limited)
Showing Closing Date Range from Sep 8 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
PACB Performance $2.87
+117.42%
Pacific Biosciences of California Inc.
Normalized Baseline0.00%
SFWL Performance $8.82
-19.16%
Shengfeng Development Limited
Normalized Baseline0.00%
Alpha Spread Margin PACB LEADS
+136.58 pts
PACB outperforming by 136.58 percentage points
PACBSFWL
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
PACB SFWL
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(19 dates)
| Date | PACB Price | PACB Gain (%) | SFWL Price | SFWL Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 05, 2026 | $2.87 | +117.42% | $8.82 | -19.16% | +136.58% |
| Oct 02, 2026 | $2.54 | +92.42% | $8.35 | -23.46% | +115.88% |
| Oct 01, 2026 | $2.51 | +90.15% | $8.81 | -19.25% | +109.40% |
| Sep 30, 2026 | $2.37 | +79.55% | $8.90 | -18.42% | +97.97% |
| Sep 29, 2026 | $1.83 | +38.64% | $8.90 | -18.42% | +57.06% |
| Sep 28, 2026 | $1.71 | +29.55% | $8.90 | -18.42% | +47.97% |
| Sep 24, 2026 | $1.46 | +10.23% | $- | - | |
| Sep 23, 2026 | $1.41 | +6.82% | $8.48 | -22.27% | +29.09% |
| Sep 22, 2026 | $- | $8.83 | -19.11% | - | |
| Sep 21, 2026 | $1.36 | +3.03% | $8.48 | -22.27% | +25.30% |
| Sep 18, 2026 | $1.37 | +3.79% | $8.28 | -24.12% | +27.91% |
| Sep 17, 2026 | $1.38 | +4.55% | $9.00 | -17.55% | +22.10% |
| Sep 16, 2026 | $1.34 | +1.52% | $9.00 | -17.51% | +19.03% |
| Sep 15, 2026 | $1.34 | +1.52% | $9.20 | -15.67% | +17.19% |
| Sep 14, 2026 | $1.35 | +2.27% | $8.19 | -24.93% | +27.20% |
Page 1 of 2